An important step towards a prevascularized islet microencapsulation device: in vivo prevascularization by combination of mesenchymal stem cells on micropatterned membranes.
An important step towards a prevascularized islet microencapsulation device: in vivo prevascularization by combination of mesenchymal stem cells on micropatterned membranes.
复制标题
DOI:
10.1007/s10856-018-6178-6
复制
发表时间:
2018-11-09
期刊:
影响因子:
--
通讯作者:
van Apeldoorn A
中科院分区:
文献类型:
--
作者:
Groot Nibbelink M;Skrzypek K;Karbaat L;Both S;Plass J;Klomphaar B;van Lente J;Henke S;Karperien M;Stamatialis D;van Apeldoorn A
Extrahepatic transplantation of islets of Langerhans could aid in better survival of islets after transplantation. When islets are transfused into the liver 60-70% of them are lost immediately after transplantation. An important factor for a successful extrahepatic transplantation is a well-vascularized tissue surrounding the implant. There are many strategies known for enhancing vessel formation such as adding cells with endothelial potential, the combination with angiogenic factors and / or applying surface topography at the exposed surface of the device. Previously we developed porous, micropatterned membranes which can be applied as a lid for an islet encapsulation device and we showed that the surface topography induces human umbilical vein endothelial cell (HUVEC) alignment and interconnection. This was achieved without the addition of hydrogels, often used in angiogenesis assays. In this work, we went one step further towards clinical implementation of the device by combining this micropatterned lid with Mesenchymal Stem Cells (MSCs) to facilitate prevascularization in vivo. As for HUVECs, the micropatterned membranes induced MSC alignment and organization in vitro, an important contributor to vessel formation, whereas in vivo (subcutaneous rat model) they contributed to improved implant prevascularization. In fact, the combination of MSCs seeded on the micropatterned membrane induced the highest vessel formation score in 80% of the sections.
登录
查看更多内容
影响因子:
14
作者:
Aubin H;Nichol JW;Hutson CB;Bae H;Sieminski AL;Cropek DM;Akhyari P;Khademhosseini A
通讯作者:
Khademhosseini A
影响因子:
14
作者:
Heilshorn, SC;DiZio, KA;Tirrell, DA
通讯作者:
Tirrell, DA
影响因子:
4.2
作者:
Grundfest-Broniatowski, Sharon F.;Tellioglu, Gurkan;Kennedy, Joseph P.
通讯作者:
Kennedy, Joseph P.
影响因子:
7.7
作者:
Harlan DM;Kenyon NS;Korsgren O;Roep BO;Immunology of Diabetes Society
通讯作者:
Immunology of Diabetes Society
影响因子:
3.8
作者:
Anderson, Deirdre E. J.;Hinds, Monica T.
通讯作者:
Hinds, Monica T.